Sonja B. Vliek

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

M. J. van de Vijver, W. V. van Harten, A. Jager, 2022, European journal of cancer.

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial

A. Jager, S. Linn, C. V. D. van de Velde, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

P. Ascierto, G. Hospers, J. Haanen, 2024, The New England journal of medicine.